CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Commercial Officer gave up 85 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 6,264 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,542 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 6,732 shares (to pay taxes)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K/A Event Acquisition or sale completed
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Financial Officer sold 41,713 shares at an average $16.15 ($673,714)
Page 5 of 22 · 426 filings